Publication date: Feb 11, 2025
Platform trials have become widely adopted across multiple disease areas over recent years, however, guidelines for operationalising these trials have not kept pace. We outline a series of documents that summarise the statistical components, and implicit processes, of the Staphylococcus aureus Network Adaptive Platform (SNAP) trial to provide an informal template for other researchers and reviewers of platform trials. We briefly summarise the content and role of the core protocol, statistical appendix, domain-specific appendices, simulation report, statistical implementation guides, data safety and monitoring committee (DSMC) reports, and domain-specific statistical analysis plans and final reports, and a transparent governance structure that ensures separate blinded and unblinded statistical teams. In the absence of guidelines or checklists for platform trial statistical documents, we hope to provide useful guidance to others in terms of what has worked so far for the SNAP trial, stimulate discussion, and inform a future consensus. Trial registration NCT05137119 . Registered on 30 November 2021.
Open Access PDF
Semantics
Type | Source | Name |
---|---|---|
disease | IDO | role |
pathway | REACTOME | Reproduction |
disease | MESH | COVID 19 pandemic |
disease | IDO | algorithm |
drug | DRUGBANK | Ranitidine |
disease | MESH | Pneumonia |
drug | DRUGBANK | Coenzyme M |
disease | MESH | confusion |
drug | DRUGBANK | Sodium hydroxide |
disease | MESH | graft versus host disease |
disease | MESH | infections |
disease | IDO | cell |
drug | DRUGBANK | Huperzine B |
disease | MESH | Infectious Diseases |
disease | IDO | infection |
drug | DRUGBANK | Trestolone |
disease | MESH | Emergency |
drug | DRUGBANK | Clindamycin |
disease | MESH | bacteremia |